Background: The effect of low-level laser therapy (LLLT) on accelerating orthodontic tooth movement has been extensively studied; however, there is limited knowledge on the use of LLLT on orthodontic root resorption.
Objective: To investigate the effect of LLLT on orthodontically induced inflammatory root resorption (OIIRR) and to compare the difference between pulsed and continuous LLLT on OIIRR.
Trial design: Double-blind, single-centre 3-arm parallel split-mouth randomized controlled trial.
Participants: Twenty adolescent patients who required bilateral maxillary first premolar (MFP) orthodontic extractions were recruited from the Sydney Dental Hospital between October 2014 and December 2014.
Intervention: All MFPs were tipped buccally for 28 days to induce OIIRR. The experimental premolars (n = 20) received LLLT and the control premolars (n = 20) received placebo-laser on days 0, 1, 2, 3, 7, 14, and 21. Ten experimental premolars received LLLT via continuous delivery and 10 received pulsed delivery.
Laser parameter: AlGaAs diode laser of 808 nm wavelength, 0.18 W power, 1.6 J per point, and duration of 9s for continuous mode and 4.5 s for pulsed mode.
Outcome: The difference in root resorption crater volume between LLLT and placebo-laser and continuous or pulsed laser delivery after 28 days.
Randomization: Randomization was computer-generated, with allocation concealment by opaque sequentially numbered sealed envelopes.
Blinding: The participants and operator were blinded.
Results: Eighty-eight patients were screened and 20 patients were randomized. Forty premolars were analysed. LLLT resulted in 23 per cent less root resorption compared to the placebo (P = 0.026). Pulsed laser delivery resulted in 5 per cent less root resorption than continuous; however, this was not statistically significant (P = 0.823). No harm was observed.
Conclusion: Teeth treated with LLLT had less total root resorption than placebo-laser. Furthermore, there was minimal difference between pulsed or continuous delivery of LLLT.
Trial registration: Clinical Trials Registry (ACTRN12616000829415).
Protocol: The protocol was not published before trial commencement.